The New Drug Reimbursement Game - A Regulator’s Guide to Playing and Winning

This comprehensive text presents a rigorous framework from within which regulators can respond strategically to the claim by the pharmaceutical industry that lower drug prices today lead to a loss for the population’s future health due to less innovation.